Primary Care Mastery
(2026/2027 Standards)
PART I: THE PRIMER
Mastery of geriatric syndromes, polypharmacy, and the 2026 biological-decoupling paradigms
separates clinical technicians from elite primary care architects. Navigating the intersection of
Ham's Primary Care Geriatrics and contemporary 2026 standards forges highly resilient
practitioners capable of averting cascading multisystem failures in the older adult.
● The AGS Beers Redline: Deprescribing is an active intervention; the 2025 guidelines
mandate cognitive behavioral therapy for insomnia (CBT-I) over Z-drugs and
benzodiazepines.
● The PREVENT Threshold: The 2025 AHA/ACC Hypertension guidelines dictate
pharmacotherapy initiation at Stage 1 (130/80 mmHg) if the 10-year PREVENT
cardiovascular risk equates to ≥7.5%.
● The GOLD Escalation: The 2026 COPD criteria classify any patient with a history of just
one moderate exacerbation directly into Group E, demanding immediate treatment
escalation.
● The 4Ms Integration: The 2026 ADA Standards and CMS Age-Friendly Hospital
Measures require universal screening of Mentation, Medications, Mobility, and What
Matters.
PART II: THE ELITE TEST BANK
Q1: The clinician is evaluating a 78-year-old patient for preoperative risk. The
chronological age is documented, but modern protocols demand biological age
decoupling. Which of the following tools provides the most highly sensitive cumulative
deficit model for comprehensive geriatric assessment? A) The SPICES Tool B) The Fried
Frailty Phenotype C) The Rockwood Frailty Index D) The PREVENT Equation
● The Answer: C (The Rockwood Frailty Index)
● Distractor Analysis: Option A is an acute symptom radar system for geriatric
syndromes, not a cumulative deficit frailty model. Option B is a physical assessment
predictor of mortality, but it evaluates phenotype, not a cumulative deficit count. Option D
evaluates 10-year cardiovascular risk, not biological frailty.
● The Mentor's Analysis: The professional must differentiate between phenotypic models
and cumulative deficit models. The Rockwood Frailty Index counts multiple health domain
impairments to generate a highly sensitive ratio, replacing chronological age as the
primary metric for surgical and clinical risk.
Frailty Model Type Clinical Application
Fried Phenotype Physical Assessment Identifies physical exhaustion,
,Frailty Model Type Clinical Application
weight loss, and weakness.
Rockwood Index Cumulative Deficit Ratios multi-domain
impairments to calculate exact
biological age risk.
Q2: During a routine evaluation, an 88-year-old frail female presents with a baseline oral
temperature of 99.0°F (37.2°C). She exhibits new-onset lethargy. Which interpretation
aligns with advanced geriatric clinical judgment? A) The temperature is within normal limits;
observe and hydrate. B) The patient is experiencing mild environmental hyperthermia. C) The
temperature indicates a blazing red flag for a lethal infection. D) The patient requires
antipyretics to prevent delirium.
● The Answer: C (The temperature indicates a blazing red flag for a lethal infection.)
● Distractor Analysis: Options A and B represent dangerous amateur traps that fail to
account for physiological changes in aging. Option D incorrectly focuses on symptom
suppression rather than identifying the underlying infectious catalyst.
● The Mentor's Analysis: Elite practitioners recognize that baseline body temperatures
drop significantly with advancing age. An oral temperature of 99.0°F in a frail 88-year-old
does not represent a normal variant; it represents a blunted, yet critical, immunological
response to a potentially lethal infection requiring immediate blood cultures.
Q3: A 74-year-old male with chronic insomnia requests a refill of zolpidem. Following the
2025 American Geriatrics Society (AGS) Beers Criteria alternatives, what is the
mandatory first-line intervention? A) Transition to an over-the-counter diphenhydramine
sleep aid. B) Initiate Cognitive Behavioral Therapy for Insomnia (CBT-I). C) Transition to a
low-dose benzodiazepine. D) Continue zolpidem but reduce the frequency to every other night.
● The Answer: B (Initiate Cognitive Behavioral Therapy for Insomnia (CBT-I).)
● Distractor Analysis: Option A utilizes first-generation antihistamines, which carry severe
anticholinergic risks and are heavily restricted on the Beers list. Option C introduces a
medication class with an identical, if not higher, risk profile for falls and cognitive
impairment. Option D maintains a potentially inappropriate medication without attempting
evidence-based alternatives.
● The Mentor's Analysis: The 2025 AGS Beers Criteria update fundamentally shifts the
paradigm from merely withholding medications to actively prescribing non-pharmacologic
alternatives. CBT-I delivered via trained therapists or digital apps is the definitive first-line
standard for late-life insomnia.
Q4: A 66-year-old female presents with a blood pressure of 134/84 mmHg. She has no
history of cardiovascular disease, diabetes, or chronic kidney disease. Her 10-year
PREVENT risk score is calculated at 8.2%. According to the 2025 AHA/ACC Hypertension
guidelines, what is the appropriate action? A) Emphasize lifestyle modifications and
reassess in one year. B) Initiate antihypertensive medication immediately if BP remains elevated
after a 3-6 month lifestyle trial. C) Withhold medication, as the pooled cohort equation is
required for confirmation. D) Prescribe a beta-blocker as monotherapy immediately.
● The Answer: B (Initiate antihypertensive medication immediately if BP remains elevated
after a 3-6 month lifestyle trial.)
● Distractor Analysis: Option A delays necessary treatment indefinitely; a structured trial
is required, not a passive one-year wait. Option C relies on the obsolete Pooled Cohort
Equations, which over-estimated risk. Option D utilizes a beta-blocker, which is not a
preferred first-line agent for primary hypertension without specific indications.
, ● The Mentor's Analysis: The 2025 AHA/ACC guidelines redefined the threshold for
intervention. Stage 1 hypertension (130-139/80-89 mmHg) coupled with a PREVENT
score of ≥7.5% requires pharmacological intervention if lifestyle modifications fail within 3
to 6 months to mitigate cardiovascular disease and mortality.
Q5: The 2026 ADA Standards of Care prioritize the 4Ms framework for older adults with
diabetes. Which of the following represents a direct application of the "Mentation"
domain in this context? A) Recommending 5-7% weight loss targets. B) Screening for mild
cognitive impairment annually to individualize A1c goals. C) Ordering a physical therapy consult
for neuropathy. D) Deprescribing sulfonylureas to prevent hypoglycemia.
● The Answer: B (Screening for mild cognitive impairment annually to individualize A1c
goals.)
● Distractor Analysis: Option A addresses metabolic factors. Option C addresses the
"Mobility" domain. Option D addresses the "Medications" domain.
● The Mentor's Analysis: The ADA 2026 guidelines dictate that early detection of cognitive
decline directly alters the trajectory of diabetes management. A patient with advancing
dementia cannot safely manage complex insulin regimens, necessitating a relaxation of
glycemic targets to prevent fatal hypoglycemic events.
Q6: A 71-year-old male with COPD has experienced one moderate exacerbation requiring
oral corticosteroids in the past 11 months. Under the 2026 GOLD Report, what is his
classification, and what is the primary therapeutic goal? A) Group B; aim for
bronchodilation. B) Group E; aim for a low disease activity state. C) Group C; aim for inhaled
corticosteroid initiation. D) Group A; aim for smoking cessation alone.
● The Answer: B (Group E; aim for a low disease activity state.)
● Distractor Analysis: Options A and D are incorrect because the patient has experienced
an exacerbation, elevating the risk profile. Option C relies on an obsolete letter
classification (C and D were removed in favor of E).
● The Mentor's Analysis: The 2026 GOLD criteria represent a critical escalation protocol.
Emerging evidence demonstrates that a single moderate exacerbation drastically
increases the risk of subsequent events. Consequently, one exacerbation automatically
places the patient in Group E, triggering immediate treatment escalation to achieve a
state of "low disease activity".
Q7: A hospital is seeking Geriatric Emergency Department Accreditation (GEDA) at Level
1. Which structural integration is a non-negotiable requirement for this top-tier
designation? A) A dedicated, physically separate waiting room for adults over 65. B) Routine
administration of prophylactic antipsychotics for agitation. C) The designation of specialized
geriatric physician and nurse champions with advanced training. D) Discontinuation of all
indwelling urinary catheters.
● The Answer: C (The designation of specialized geriatric physician and nurse champions
with advanced training.)
● Distractor Analysis: Option A is a misconception; GED care integrates into the existing
ED space rather than isolating it. Option B is contraindicated and violates Beers Criteria.
Option D is a protocol goal (minimizing use) but absolute discontinuation is not a
structural requirement.
● The Mentor's Analysis: GEDA Level 1 requires systemic, cultural, and operational
overhauls. It mandates specific educational competencies, including designated physician
and nurse champions trained in the eight domains of geriatric emergency medicine,
ensuring leadership drives the protocol execution.
Q8: An 82-year-old hospitalized patient exhibits acute-onset fluctuating confusion and